© 2025 MJH Life Sciences™ , Patient Care Online – Primary Care News and Clinical Resources. All rights reserved.
Latest Conference Articles
These Two Words Could Change Obesity Treatment, says Harold Bays, MD
April 23rd 2021
Long time cardiometabolic investigator Harold Bays, MD, talks about obesity, new drugs to treat the disease, and how the words "be inefficient" could change thinking about treatment.
Starting a Dialogue about Obesity in Primary Care: Respect is Key
April 22nd 2021
Primary care physicians face unique challenges when managing patients with obesity, but one obesity specialist aims to show clinicians how to meet them, even if it's in small ways.
Obesity Expert Discusses an Unexpected Metabolic Response to Weight Loss
April 22nd 2021
Citing a study of "The Biggest Loser" participants, obesity expert Dr Silvana Pannain explains why "Eat less, exercise more," often backfires as a sole intervention for persons with obesity.
Keith C. Ferdinand, MD: COVID-19, Obesity, and the African American Community
April 19th 2021
Keith C Ferdinand, MD, discusses how deeply-rooted social determinants of health have led to the vastly disproportionate impact of COVID-19 on persons of color.
Guideline-directed Osteoporosis Treatment Found in Decline
March 19th 2021
ENDO 2021: Fewer than 1-in-10 older adults with a hip fracture had been prescribed bone-directed treatment in the 6 months prior to the incident, according to research on trends in treatment.
Dapagliflozin Effective in T2D with HFrEF Regardless of Type of Background T2D Therapy
June 19th 2020
VIDEO: Kieran Docherty, MBChB, discusses results of the DAPA-HF analysis on the impact of background T2D therapy on clinical outcomes in patients with T2D and HFrEF.
Glycemic Control in US Youth, Young Adults Disappointing
June 17th 2020
ADA 2020. Average A1c for a recent young cohort with type 2 diabetes was 8.5%, according to research presented at the ADA Virtual Scientific Sessions.
Physician CKD Awareness in T2D Patients Linked to CKD Severity
June 17th 2020
Physicians’ CKD awareness in T2D is linked with CKD severity, suggests a new study presented this week at the American Diabetes Association’s 80th Virtual Scientific Sessions.
DAPA-HF: Dapagliflozin Reduces Incident T2D in Adults with Heart Failure
June 16th 2020
VIDEO: Silvio Inzucchi, MD, discusses results of a prespecified analysis of the DAPA-HF trial, which found that dapagliflozin reduced new onset diabetes by 32% in patients with heart failure.
Rushed HCP Interactions with Black Patients Erode Glycemic Control
June 16th 2020
ADA 2020: Glycemic control was worse for black patients who experienced hurried interaction with healthcare providers than for those who did not, a new study reports.